Print

Print


Lawmakers Weigh Human Organism Patent Ban
By JIM ABRAMS
The Associated Press
Wednesday, November 26, 2003; 1:20 PM

WASHINGTON - The U.S. Patent Office would be barred from issuing patents on human organisms, such as genetically
engineered embryos, under an agreement reached by lawmakers.

Rep. Dave Weldon, R-Fla., a medical doctor who sponsored the provision to be included in a giant spending bill, said it
would codify existing Patent Office rules that human organisms are not patentable subject matter.

Weldon said an agreement was worked out Monday with senators to make clear, in a report accompanying the provision,
that the patent ban would not interfere with stem cell research.

The provision would ban patents for genetically engineered human embryos, fetuses and human beings, but would not
affect patents on genes, cells, tissue and other biological products. It would also not stop scientists from seeking
patents for the procedures or methods of creating a biological product.

U.S. Patent and Trademark Office director James Rogan, in a letter last week to Senate Appropriations Committee
Chairman Ted Stevens, R-Alaska, said his office viewed the Weldon amendment as "fully consistent with USPTO's policy on
the non-patentability of human life-forms."

He said the measure gave "unequivocal congressional backing" for a rule "refusing to grant any patent containing a
claim that encompasses any member of the species Homo sapiens at any stage of development."

Weldon said in a recent floor speech that his amendment would leave the Patent Office free to address new or borderline
issues. As an example, he noted that the Patent Office does grant patents in cases where an animal has been modified to
include a few human genes so it can produce a human protein or antibody.

The Biotechnology Industry Organization has voiced concerns about the amendment, saying the language is vague and would
jeopardize many human-derived biotechnology inventions. It warned that investors, fearing a lack of patent protection,
would not invest when there is no clear definition of what encompasses a human organism.

"The biotechnology industry has been fighting this tooth and nail," Weldon said.

The amendment last July was attached to the House version of a 2004 spending bill for the departments of Commerce,
Justice and State. The bill is included in a package of unfinished spending bills that Congress is expected to approve
and send to the president next week.

Weldon was also the sponsor earlier this year of legislation that would impose a total ban on all human cloning. The
bill passed the House but has stalled in the Senate.

---

On the Net:

Rep. Dave Weldon: http://www.house.gov/weldon/

Biotechnology Industry Organization: http://www.bio.org/

SOURCE: The Washington Post, DC
http://www.washingtonpost.com/wp-dyn/articles/A16205-2003Nov26.html

* * *

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn